PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 134 filers reported holding PTC THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $210,654 | -59.2% | 9,400 | -26.0% | 0.00% | -60.0% |
Q2 2023 | $516,509 | +27.7% | 12,700 | +19.8% | 0.01% | +25.0% |
Q4 2022 | $404,602 | -32.8% | 10,600 | -11.7% | 0.00% | -42.9% |
Q3 2022 | $602,400 | +123.9% | 12,000 | +172.7% | 0.01% | +133.3% |
Q4 2020 | $269,000 | +10.2% | 4,400 | -8.3% | 0.00% | 0.0% |
Q2 2020 | $244,000 | -58.5% | 4,800 | -72.4% | 0.00% | -57.1% |
Q3 2019 | $588,000 | -27.9% | 17,400 | -3.9% | 0.01% | -22.2% |
Q2 2019 | $815,000 | +19.7% | 18,100 | 0.0% | 0.01% | +12.5% |
Q1 2019 | $681,000 | -3.7% | 18,100 | -12.1% | 0.01% | -20.0% |
Q4 2018 | $707,000 | -27.0% | 20,600 | 0.0% | 0.01% | -9.1% |
Q3 2018 | $968,000 | -40.5% | 20,600 | -57.3% | 0.01% | -45.0% |
Q2 2018 | $1,626,000 | +334.8% | 48,200 | +157.8% | 0.02% | +300.0% |
Q3 2017 | $374,000 | +11.0% | 18,700 | +1.6% | 0.01% | +25.0% |
Q2 2017 | $337,000 | +80.2% | 18,400 | -3.2% | 0.00% | +100.0% |
Q1 2017 | $187,000 | -19.0% | 19,000 | +400.0% | 0.00% | -33.3% |
Q1 2015 | $231,000 | – | 3,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 8,180 | $382,000 | 7.47% |
Burrage Capital Management LLC | 173,545 | $8,113,000 | 6.40% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 299,000 | $13,951,000 | 4.50% |
RTW INVESTMENTS, LP | 3,993,286 | $186,686,000 | 4.50% |
SECTORAL ASSET MANAGEMENT INC | 669,578 | $31,303,000 | 2.69% |
Third Security, LLC | 255,873 | $11,962,000 | 2.48% |
Sofinnova Investments, Inc. | 405,152 | $18,941,000 | 1.40% |
ARMISTICE CAPITAL, LLC | 724,000 | $33,847,000 | 1.23% |
Redwood Investments, LLC | 225,355 | $10,535,000 | 0.89% |
Handelsinvest Investeringsforvaltning | 60,000 | $2,805,000 | 0.53% |